{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:14:28Z","timestamp":1778746468358,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 RR024131"],"award-info":[{"award-number":["UL1 RR024131"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010511","name":"Clinical and Translational Science Institute, University of California, San Francisco","doi-asserted-by":"publisher","award":["UL1 RR024131"],"award-info":[{"award-number":["UL1 RR024131"]}],"id":[{"id":"10.13039\/100010511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH083784-10"],"award-info":[{"award-number":["R01 MH083784-10"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.psyneuen.2024.107045","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T17:32:14Z","timestamp":1712424734000},"page":"107045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder"],"prefix":"10.1016","volume":"165","author":[{"given":"Anna J.T.","family":"Smit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwyneth W.Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Rampersaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor I.","family":"Reus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen M.","family":"Wolkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Synthia H.","family":"Mellon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2024.107045_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.626906","article-title":"Blood brain-derived neurotrophic factor (BDNF) and major depression: do we have a translational perspective?","volume":"15","author":"Arosio","year":"2021","journal-title":"Front Behav. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107045_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/ijp.IJP_700_16","article-title":"The impact of antidepressant treatment on brain-derived neurotrophic factor level: An evidence-based approach through systematic review and meta-analysis","volume":"49","author":"Arumugam","year":"2017","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.psyneuen.2024.107045_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pnpbp.2008.11.016","article-title":"Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients","volume":"33","author":"Ba\u015fterzi","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib4","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/npp.2011.318","article-title":"BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity","volume":"37","author":"Bath","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2024.107045_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/appi.ajp.2018.18070881","article-title":"No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples","volume":"176","author":"Border","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.psyneuen.2010.07.013","article-title":"Determinants of serum brain-derived neurotrophic factor","volume":"36","author":"Bus","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2024.107045_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2015.05.027","article-title":"Neurotrophic factors in depression in response to treatment","volume":"183","author":"Buttensch\u00f8n","year":"2015","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psyneuen.2024.107045_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbi.2020.04.039","article-title":"Altered peripheral blood compounds in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"88","author":"\u00c7akici","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2024.107045_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/15622975.2017.1347713","article-title":"Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression","volume":"19","author":"Caldieraro","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.psyneuen.2024.107045_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105159","article-title":"The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: insight from meta-analyses","volume":"149","author":"Cavaleri","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2024.107045_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jnr.23863","article-title":"Sex differences in brain-derived neurotrophic factor signaling and functions","volume":"95","author":"Chan","year":"2017","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.psyneuen.2024.107045_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jad.2010.07.006","article-title":"Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder","volume":"126","author":"Chi","year":"2010","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psyneuen.2024.107045_bib14","first-page":"213","article-title":"Serum brain-derived neurotrophic factors in taiwanese patients with drug-na\u00efve first-episode major depressive disorder: effects of antidepressants","volume":"20","author":"Chiou","year":"2017","journal-title":"Int J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.107045_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2015.01.013","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients","volume":"175","author":"Colle","year":"2015","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psyneuen.2024.107045_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214445","article-title":"BDNF as a mediator of antidepressant response: recent advances and lifestyle interactions","volume":"23","author":"Cubillos","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.psyneuen.2024.107045_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.psychres.2016.04.034","article-title":"Socio-demographic and clinical predictors of non-response\/non-remission in treatment resistant depressed patients: a systematic review","volume":"240","author":"De Carlo","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2024.107045_bib18","first-page":"54","article-title":"Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment","volume":"46","author":"Deuschle","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ejn.14630","article-title":"Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants","volume":"53","author":"Duman","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107045_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.psyneuen.2024.107045_bib21","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jpsychires.2012.05.003","article-title":"Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level","volume":"46","author":"Elfving","year":"2012","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.psyneuen.2024.107045_bib22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/life13071555","article-title":"Variation of circulating brain-derived neurotrophic factor (BDNF) in depression: relationships with inflammatory indices, metabolic status and patients' clinical features","volume":"13","author":"Falaschi","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.psyneuen.2024.107045_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145709991039","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders?","volume":"13","author":"Gass","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.107045_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.mp.4002075","article-title":"Is it time to reassess the BDNF hypothesis of depression?","volume":"12","author":"Groves","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br. J. Soc. Clin. Psychol."},{"key":"10.1016\/j.psyneuen.2024.107045_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2007-1004594","article-title":"Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment","volume":"41","author":"Hellweg","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10519-011-9504-z","article-title":"Editorial policy on candidate gene association and candidate gene-by-environment interaction studies of complex traits","volume":"42","author":"Hewitt","year":"2012","journal-title":"Behav. Genet."},{"key":"10.1016\/j.psyneuen.2024.107045_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.psyneuen.2018.12.015","article-title":"Serum brain-derived neurotrophic factor (BDNF) at rest and after acute aerobic exercise in major depressive disorder","volume":"102","author":"Kallies","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2024.107045_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","article-title":"Decreased serum brain-derived neurotrophic factor levels in major depressed patients","volume":"109","author":"Karege","year":"2002","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psyneuen.2024.107045_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/WNN.0000000000000089","article-title":"Elevated brain-derived neurotrophic factor correlates negatively with severity and duration of major depressive episodes","volume":"29","author":"Kheirouri","year":"2016","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.psyneuen.2024.107045_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fpsyt.2017.00308","article-title":"Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses","volume":"8","author":"Kishi","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115283","article-title":"Exercise elevates serum brain-derived neurotrophic factor in partially remitted depression","volume":"326","author":"Kramer","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2024.107045_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41398-019-0460-3","article-title":"Prognosis and improved outcomes in major depression: a review","volume":"9","author":"Kraus","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127643","article-title":"Blood BDNF level is gender specific in severe depression","volume":"10","author":"Kreinin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2024.107045_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neurobiolaging.2021.01.020","article-title":"BDNF serum concentrations in 2053 participants of the Berlin Aging Study II","volume":"101","author":"Kronenberg","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.psyneuen.2024.107045_bib36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","volume":"10","author":"Martinowich","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107045_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpsychires.2008.03.014","article-title":"Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine","volume":"43","author":"Matrisciano","year":"2009","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.psyneuen.2024.107045_bib38","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00213-014-3475-8","article-title":"High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression","volume":"231","author":"Mikoteit","year":"2014","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.psyneuen.2024.107045_bib39","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/mp.2010.98","article-title":"Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment","volume":"16","author":"Molendijk","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)","volume":"197","author":"Molendijk","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib41","article-title":"Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)","volume":"10","author":"Mosio\u0142ek","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.psyneuen.2024.107045_bib42","doi-asserted-by":"crossref","unstructured":"Naegelin, Y., Dingsdale, H., S\u00e4uberli, K., Sch\u00e4delin, S., Kappos, L., & Barde, Y.A., 2018. Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum. eNeuro, 5, ENEURO.0419-17.2018.","DOI":"10.1523\/ENEURO.0419-17.2018"},{"key":"10.1016\/j.psyneuen.2024.107045_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000442607","article-title":"Role of serum brain derived neurotrophic factor and central N-acetylaspartate for clinical response under antidepressive pharmacotherapy","volume":"24","author":"Nase","year":"2016","journal-title":"Neurosignals"},{"key":"10.1016\/j.psyneuen.2024.107045_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113931","article-title":"Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: a step towards personalized therapy","volume":"430","author":"Pathak","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2024.107045_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/srep17989","article-title":"A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays","volume":"5","author":"Polacchini","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psyneuen.2024.107045_bib46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psyneuen.2024.107045_bib47","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/ajp.145.7.844","article-title":"Graphic representation of the life course of illness in patients with affective disorder","volume":"145","author":"Post","year":"1988","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000507371","article-title":"Association of serum biomarker levels and BDNF gene polymorphism with response to selective serotonin reuptake inhibitors in indian patients with major depressive disorder","volume":"80","author":"Ramesh","year":"2021","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2024.107045_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00406-022-01418-4","article-title":"Predicting treatment outcome in depression: an introduction into current concepts and challenges","volume":"273","author":"Rost","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107045_bib50","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","article-title":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis","volume":"41","author":"Shi","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.107045_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharep.2017.08.002","article-title":"Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression","volume":"70","author":"Skibinska","year":"2018","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.psyneuen.2024.107045_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08039488.2017.1415373","article-title":"Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters","volume":"72","author":"Skibinska","year":"2018","journal-title":"Nord J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib54","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/15622975.2011.616533","article-title":"Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study","volume":"14","author":"Terracciano","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fnmol.2018.00156","article-title":"Critical issues in BDNF Val66Met genetic studies of neuropsychiatric disorders","volume":"11","author":"Tsai","year":"2018","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107045_bib56","unstructured":"Williams, J., Terman, M., 2003. STRUCTURED INTERVIEW GUIDE FOR THE HAMILTON DEPRESSION RATING SCALE with Atypical Depression Supplement (SIGH-ADS 2003)."},{"key":"10.1016\/j.psyneuen.2024.107045_bib57","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.pnpbp.2011.06.013","article-title":"Serum BDNF levels before treatment predict SSRI response in depression","volume":"35","author":"Wolkowitz","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib58","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.pnpbp.2011.02.009","article-title":"The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients","volume":"35","author":"Yoshimura","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib59","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.pnpbp.2007.03.001","article-title":"Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients","volume":"31","author":"Yoshimura","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib60","article-title":"Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression","volume":"12","author":"Zhou","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.psyneuen.2024.107045_bib61","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1176\/appi.ajp.2018.18091079","article-title":"General predictors and moderators of depression remission: a VAST-D report","volume":"176","author":"Zisook","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107045_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.euroneuro.2009.12.005","article-title":"Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder","volume":"20","author":"Zou","year":"2010","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:59:02Z","timestamp":1778745542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453024000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":62,"alternative-id":["S0306453024000891"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.107045","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.107045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107045"}}